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http://www.biomedcentral.com/1471-244X/14/58STUDY PROTOCOL Open AccessTreatment of bipolar disorder in the Netherlands
and concordance with treatment guidelines:
study protocol of an observational, longitudinal
study on naturalistic treatment of bipolar disorder
in everyday clinical practice
Joannes W Renes1*, Eline J Regeer1, Trijntje YG van der Voort2, Willem A Nolen3 and Ralph W Kupka1,2Abstract
Background: While various guidelines on the treatment of bipolar disorder have been published over the last
decades, adherence to guidelines has been reported to be low. In this article we describe the protocol of a
nationwide, multicenter, longitudinal, non-intervention study on the treatment of bipolar disorder in the
Netherlands. Study aims are to provide information on the nature and content of outpatient treatment of bipolar
disorder, to determine to what extent treatment is in concordance with the Dutch guideline for the treatment of
bipolar disorder (2008), and to investigate the relationship of guideline concordance with symptomatic and
functional outcome.
Methods/Design: Between December 2009 and February 2010, all psychiatrists registered as member of the Dutch
Psychiatric Association received a questionnaire with questions about their treatment setting, and whether they
would be willing to participate in further research. Psychiatrists treating adult outpatients with bipolar disorder were
invited to participate. Consenting psychiatrist subsequently approached all their patients with bipolar disorder. The
study is performed with written patient and caregiver surveys at baseline and after 12 months, including data on
demographics, illness characteristics, organization of care, treatments received, symptomatic and functional
outcome, quality of life, and burden of care for informal caregivers.
Discussion: This study will provide information on the naturalistic treatment of bipolar disorder in the Netherlands,
as well as degree of concordance of this treatment with the Dutch guideline, and its relationship with symptomatic
and functional outcome. Limitations of a survey-based study are discussed.
Keywords: Bipolar disorder, Clinical practice, Guidelines, Care as usualBackground
Bipolar disorder is a severe mental disorder characterized
by recurrent episodes of mania, hypomania, depression, or
mixed episodes. The estimated lifetime prevalence of bi-
polar disorder ranges from 1,5 to 2% [1]. Many patients
with bipolar disorder do not regain full psychosocial func-
tioning between episodes and health related quality of life* Correspondence: j.renes@altrecht.nl
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Utrecht, The Netherlands
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unless otherwise stated.is adversely affected for many patients [2,3]. Although pa-
tients themselves are most affected by the illness, informal
caregivers also report distress and have difficulties in cop-
ing with the illness [4].
To improve quality of care, various guidelines on the
treatment of bipolar disorders have been published over
the last decades. Recent studies on collaborative care pro-
grams for bipolar disorders [5-8] show that patients treated
in speciality programs (consisting of an intensive follow-
up by a psychiatric nurse, a psycho-education program,
algorithm-based advices on medication treatments for thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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deal with manic and depressive symptoms) have less
manic symptoms and spent less time in manic episodes
compared with patient treated with care as usual. Patients
also report better quality of life and improved social func-
tioning. Recently, Kessing et al. [9] showed that patients
with bipolar disorder in the early course of their illness
had a more favorable outcome when treated in a special-
ized mood disorder clinic versus standard outpatient treat-
ment. As was shown in the Texas Medication Algorithm
Project [10] patients with bipolar disorder show a signifi-
cant improvement in psychiatric symptoms when medica-
tion algorithms are implemented in their treatment. It can
be assumed that when patients are treated according to
guidelines, quality of care as well as treatment outcome
will improve.
Although little research has been done on adherence
to guidelines for the treatment of bipolar disorder in
daily practice [11], there is some evidence that without
specific interventions adherence to guidelines by care
providers is low.
Using data from a U.S. medical benefits database,
Baldessarini et al. [12] reported that only a quarter of
7760 patients with bipolar disorder in a large community
sample was using a mood stabilizer as initial monother-
apy. A retrospective study among 1471 bipolar I patients
who were discharged from hospital showed that when
patients were admitted because of a manic or depressive
episode, treatment followed guidelines in patients with-
out psychotic features in only 16% and 17% respectively
[13]. Percentages were higher in patients with psychotic
features but still only 38% for patients with psychotic
mania and 31% for patients with psychotic bipolar depres-
sion. Using data from the National Ambulatory Medical
Care Survey, which is conducted annually by the National
Center for Health Statistics in the U.S. and samples a rep-
resentative group of visits to physicians in office-based
practices, Blanco et al. [14] analysed medication treatment
in 865 visits to a psychiatrist by patients with a diagnosis
of bipolar disorder. Also in this study, mood stabilizers
were underused.
As expected, treatment in university and tertiary centers
had greater concordance with guidelines. Of the first
500 patients entering the U.S. Systematic Treatment
Enhancement Program for Bipolar Disorder (STEP-BD),
72% were taking a mood stabilizer [15]. Although certain
multifaceted and resource-intensive interventions in
research settings improve adherence to treatment guide-
lines, after cessation of these interventions, adherence rates
returned to pre-intervention levels [11].
To improve our knowledge on the implementation of
treatment guidelines for bipolar disorder in daily clinical
practice, and the relationship of concordance with guide-
lines with clinical and other outcomes, further studies arewarranted. In 2008, a revised guideline for the diagnosis
and treatment of bipolar disorder was published by the
Dutch Psychiatric Association [16].
The study described in this article is an ongoing
nation-wide study in the Netherlands among patients
with bipolar disorder or schizoaffective disorder, their
treating psychiatrists, and important significant others
of participating patients. The purpose of the current
study is to investigate current practice for patients with
bipolar disorder or schizoaffective disorder in various
treatment settings in the Netherlands, to assess concord-
ance of provided treatments with the Dutch guideline and
to assess the relationship of concordance with the guideline
with symptomatic and functional outcome, quality of life,
and satisfaction with care as reported by patients, and with
the burden of care as perceived by significant others. Since
the care recommended in the Dutch guideline for bipolar
disorder resembles the previous mentioned speciality
programs in many ways, concordance with the guideline
is expected to improve quality of care and favor treatment
outcome. In addition, factors that influence concordance
with the guideline will also be investigated.
Methods/Design
Study design
This is a non-interventional, multicenter study with one
year follow-up among patients with bipolar I disorder,
bipolar II disorder, bipolar disorder not otherwise speci-
fied, or schizoaffective disorder, bipolar type, age 18 years
and older. Patients with these disorders are included in
the study since the Dutch guideline for bipolar disorder
applies to these diagnostic categories. Since the purpose
of the study is to provide valid information on naturalis-
tic treatment in every day clinical practice and to investi-
gate concordance with the current Dutch guideline for
the treatment of bipolar disorder, the influence of the
study on ongoing treatments should be as minimal as
possible. To collect information on every day clinical prac-
tice, psychiatrists and patients from a wide range of treat-
ment settings including non-specialised centers are asked
to participate in the study. To minimize the effort to par-
ticipate, the study is carried out with written surveys only,
at two consecutive moments in time. Participating psychi-
atrists receive a survey about the organisation of care for
patients with bipolar disorder in their treatment center or
private practice at study entry and one year later. At base-
line they are asked to invite all their eligible patients to
participate in the study. At study entry and at one year
follow-up patients receive two surveys, one for themselves
and one for a significant other (informal caregiver). The
survey for patients includes questions about illness charac-
teristics, treatments received in the prior 12 months, and
outcome measurements. Although 12 months follow-up
may seem long and may cause some recall bias, 12-months
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may receive no care within a shorter duration of follow-up.
And since one of the aims of the study is to investigate
whether improvement in concordance with the guideline
over time may lead to better quality of care and treatment
outcome, enough time between measurements is needed to
make changes in the care provided possible. Significant
others receive a questionnaire about the burden of care.
Information about individual treatments is given by the
patients, since it is assumed that patients can report more
accurately on the treatments they receive than treating
health care providers, and to reduce the burden to partici-
pate for the latter. Moreover, health care providers may
not be aware of whether patients are compliant or not. Also
when this information is provide by health care providers
it may influence the care they provide, and subsequently
influence concordance with the guideline.
Ethical considerations
The study protocol was approved by the Medical Ethical
Committee of the University Medical Center Utrecht,
The Netherlands, and was in addition independently
reviewed by the scientific committees of the two main
research centers, Altrecht Institute for Mental Health
Care, Utrecht, The Netherlands, and GGZ inGeest/VU
University Medical Center, Amsterdam, The Netherlands.
All participating patients gave informed consent. Data
are stored in a research database in accordance with the
Dutch Data Protection Authority.
Study population
Since the long-term treatment of bipolar disorder mainly
takes place in outpatient settings, only patients treated
there are included in the study. In the Netherlands general
practitioners mostly refer patients with bipolar disorder to
psychiatric treatment settings (mental health institutions,
psychiatric departments of general hospitals, academic
centers, or private practices). Therefore general practitioners
and bipolar patients treated only by general practitioners are
not included in the study. To be able to include psychiatrists
and patients from a wide range of treatment settings,
an exploratory survey was held prior to the start of the
current study, between December 2009 and February
2010, among all 2525 psychiatrists who are member of
the Dutch Psychiatric Association. All members were
approached with a 5-item questionnaire about their treat-
ment setting, the number of patients with bipolar disorder
they treat, and whether they would be willing to participate
in further research on the treatment of bipolar disorder.
Reminders were sent to all non-responding psychiatrists.
Of the 2525 psychiatrists 1579 (62.5%) responded of whom
616 (24.4%) were willing to participate in further research.
Participating psychiatrists identified all eligible patients with
a bipolar or schizoaffective disorder. Only patients unableto read Dutch or understand the questionnaires were ex-
cluded from participation in the study. There are no other
exclusion criteria. The study is planned to end mid 2014.
Methods of inclusion
Of the psychiatrists who responded to the explorative sur-
vey and were willing to participate in further research, five
hundred and forty (21.4%) were treating adult patients with
bipolar disorder, and were subsequently invited to partici-
pate in the current study. They received the baseline survey
with more detailed questions about their treatment setting
(including degree of specialisation in the treatment of mood
disorders, composition of treatment staff, education on
bipolar disorder of health care providers, and use of
disorder-specific outcome measurements), and the number
of patients potentially eligible for the study. Psychiatrists
(N = 65) only treating children with bipolar disorder were
not included. Psychiatrists who returned the survey subse-
quently received envelopes with information about the
study and an informed consent form, to send to all eligible
patients. Patients were only included in the study after
the investigators had received a signed informed consent
form. Patients then received the surveys, to be returned to
the investigators. Since it was anticipated that only a propor-
tion of eligible patients would participate, psychiatrists were
asked to keep a record including information on age, gender,
and type of bipolar disorder of all patients who would be
invited. It will then be possible to compare participating
patients with eligible patients who did not participate to
make an estimate of the generalizability of the results. Of
all participating patients a DSM-IV-TR axes I and II classi-
fication is obtained from the treating psychiatrists.
Measurements
Measurements take place at baseline and at 12 month
follow-up in patients, psychiatrists and significant others
(Table 1). Since the study is carried out with surveys only,
some scales were adapted to serve as self-administrated
instruments. The following outcome measurements are
collected at both time points. Global clinical outcome:
a modified self rated version of the Clinical Global
Impression scale for Bipolar disorder (CGI-BP). The
CGI-BP measures global symptom severity and impact
on functioning, as well as change over time. We used
only the scale for change, i.e., improvement or worsening of
symptoms and functioning in comparison with 12 month
before. Although the original clinician-rated CGI-BP-
change has been validated [17], there are currently no
data available on a self-rating version that we are aware
of. A problem with a self-rating version may be that
patients may overestimate or underestimate symptoms
and functioning in comparison with a clinician rating.
Severity of symptoms: the Quick Inventory of Depressive
Symptomatology (QIDS-SR) for assessment of depressive
Table 1 Study plan and assessments
Baseline 12 month
follow-up
Demographics x Cultural background, marital status, gender, age, level and total years of
education, and professional status
Illness characteristics x Age of onset, total number of episodes and admissions, suicide attempts,
severity of mood symptoms, family history of psychiatric disorders,
substance abuse
Treatment information x x Health care providers involved, agreement on treatment plan, follow-up
patterns, type of maintenance pharmacotherapy, participation in group
and non-drug therapies (psycho-education, use of an emergency plan
and prospective lifechart, social rhythm and other psychotherapies)
Clinical outcome x x CGI-BP-change (modified), QIDS-SR, ASRM
Satisfaction with care x x 10 point Likert scale
Quality of life x x WHOQoL-bref
Functioning x x FAST (modified)
Adherence x x DAI-10
Burden of care x x BES
Treatment center information x x Treatment setting, composition of treatment staff, availability of group
psychoeducation program, use of rating scales, additional training in
the treatment of bipolar disorder (e.g. attendance of conferences,
training programs), number of patients with bipolar disorder treated
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good psychometric properties [18]. The Altman Self-Rating
Mania Scale (ASRM), a self-administrated rating scale
for the assessment of manic symptoms. This scale has
been validated in international studies [19]. Satisfaction
with care: scoring by patients on satisfaction of the treat-
ment received with a scoring between 0 (very unsatisfied,
worst possible treatment) and 10 (very satisfied, best pos-
sible treatment). Quality of life: the WHOQoL-bref, a short
version (26 items) of the original 100 items scale developed
by the WHO for the measurement of health related quality
of life. The Dutch version was studied in 533 patients [20].
Functioning: a modified self-rated version of the
Functioning Assessment Short Test (FAST), a brief instru-
ment designed to assess the main functioning problems
experienced by psychiatric patients, particularly bipolar pa-
tients; the clinician-rated FAST was described and validated
by Rosa et al. [21]. There is discussion on patients’ ability to
score quality of life or functioning on self-rating scales, as it
may be biased by mood state. Given the design of this study
it was not possible to implement clinicians rating scales.
Adherence to treatment: patients’ subjective sensations
or beliefs with medication is measured with the Drug
Attitude Inventory (DAI-10). The DAI-10 is originally
designed to discriminate the compliance rate in schizo-
phrenic patients, but can be used in other psychiatric
disorders as well [22]. Patients are asked to their opinion
with a true or false answer on 10 statements concerning
the use of medication.
Burden of care: the “Betrokkenen Evaluatie Schaal” (BES),
a scale for the assessment of consequences for caregivers ofpatients with severe mental illness, developed and validated
in the Netherlands by van Wijngaarden et al. [23].
Concordance with Dutch guideline for bipolar disorder
The Dutch guideline for the diagnosis and treatment of
patients with bipolar disorders (further referred to as: “the
guideline”) distinguishes between treatment modalities as
recommended/obligatory for all patients (pharmacotherapy,
providing information about the illness and the treatment
alternatives, participation in a psychoeducation program, and
interventions aimed at improving self-management) and as
optional only for specific patient groups (psychotherapy
and supportive treatment with rehabilitation interventions
based on assessment of needs).
Since this study is performed with surveys only, there
are some limitations in the assessment of whether certain
treatment modalities were applied. For example, regarding
individual psychoeducation and self-management, which
includes a wide variety of interventions, obtaining stan-
dardized information is less feasible.
Concordance with the guideline will be assessed for the
following treatment modalities (Table 2). Psychoeducation:
taking part in a group psychoeducation program is rec-
ommended for all patients. Use of an emergency plan on
how to deal with early symptoms of a new mood episode
is considered an important self-management tool and
its use is recommended for unstable patients, although
instability of mood is not further specified in the guideline.
We consider patients to be unstable when at least one
mood episode occurred in the previous 12 months, being
currently symptomatic, or requiring more than four visits
Table 2 Criteria for concordance with the Dutch guideline for diagnosis and treatment of bipolar disorder [16]
Treatment modalities Criteria for concordance with the Dutch guideline
Group psycho-educationa All patients
Emergency plan on how to deal with emerging mood symptoms All instable patients. (A mood episode in the previous
12 month, currently symptomatic, more than four visits a year)
Maintenance pharmacotherapy Patients with three or more episodes lifetime or a history with one or
two severe episodes and/or a positive family history of bipolar disorder
Use of prospective lifechart Rapid cycling, a mood episode in the previous 12 months or currently
symptomatic despite maintenance pharmacotherapy
Specific psychotherapy for bipolar disorder and/or supportive treatment Instability despite medication and participation in a group
psychoeducation program
aIn the Netherlands a group psycho-education program described by Hofman et al. [24] is advised for all patients. This program consists of 6 sessions for patients
and caregivers.
Renes et al. BMC Psychiatry 2014, 14:58 Page 5 of 7
http://www.biomedcentral.com/1471-244X/14/58with a mental health care provider in the past year. The
latter is based on the assumption that in the Netherlands
most patients without comorbid disorders will not have
more than four visits a year with a mental health care pro-
vider when their mood is stable. The frequency of four
visits per year is based on the fact that in the guideline
measurement of lithium serum levels is recommended at
3–6 months intervals and that prescription of medication
is allowed for a maximum duration of three months.
Maintenance pharmacotherapy: maintenance pharmaco-
therapy is considered to be concordant with the guideline
when medication recommended for maintenance therapy
is used. In the guideline maintenance pharmacotherapy
is indicated in all patients with three or more previous
episodes. For patients with only one or two previous epi-
sodes, maintenance pharmacotherapy is indicated when at
least one of the episodes was severe or when there is a
first-degree relative with bipolar disorder.
Use of a prospective lifechart: in the guideline use of a
prospective lifechart for continuous mood-monitoring
is recommended for patients with mood instability
(rapid cycling) or treatment resistance. Apart from rapid
cycling in the past year, we consider a breakthrough mood
episode in the previous 12 months or currently being
symptomatic despite maintenance medication an indication
for the use of a prospective lifechart. In the guideline
specific psychotherapy for bipolar disorder and supportive
treatment are recommended as optional treatment indi-
cated for various patient groups.
Due to the study design, information on patients
groups for which these optional modules would be in-
dicated is however limited. To assess concordance with
the guideline we therefore limited the recommendation
for specific psychotherapy for bipolar disorder and/or
supportive treatment to patients who are unstable despite
medication and psychoeducation. Supportive treatment is
defined by the participation of a mental health nurse in
the treatment.
With these criteria for concordance with the guideline,
three groups of patients can be distinguished requiringdifferent treatment modalities to be minimally part
of the treatment: 1. Patients without an indication for
maintenance pharmacotherapy and currently stable, for
which minimally participation in a group psychoeduca-
tion program is required, 2. Patients with an indication
for maintenance pharmacotherapy and currently stable,
requiring both participation in a group psychoeducation
program and maintenance pharmacotherapy, and 3.
patients currently unstable despite medication and psy-
choeducation, requiring all above mentioned treatment
modalities.
Factors influencing concordance with the guideline
One of the aims of this study is to investigate which
factors are associated with concordance with the treat-
ment guideline, in particular whether patients treated
in specialized outpatient centers in the Netherlands receive
treatment that is more in concordance with the guideline.
Three degrees of specialization are distinguished. Centers
treating patients from different diagnostic groups, centers
treating patients with mood disorders and centers treating
only patients with bipolar disorder. In addition to the de-
gree of specialization of treatment centers, demographics,
illness characteristics, provision of care by the same health
care provider and agreement on treatment plan by the
patients will be investigated as factors that influence
concordance with the guideline.
Statistical analysis
Descriptive statistics will be used and include frequency
tables, (n, mean, median, standard deviations, minimum
and maximum for continuous measures and n, frequencies
and percentages for categorical measures). Two-sided 95%
confidence intervals will be obtained. For the associations
between patients’ characteristics, concordance with treat-
ment guideline (as independent variable) and outcome
measures, general and logistic models are planned. Odds
ratios and 95% confidence intervals will be reported and
P values for differences between groups for concordance
with treatment guideline.
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The main aim of the study is to describe outpatient care
as usual for bipolar patients in the Dutch population.
Therefore no minimal sample size was set prior to the
study; inclusion procedures were designed to include as
many as possible patients from as many different treatment
settings as possible.
Discussion
This is the first nationwide study on the quality of care
for patients with bipolar disorder in the Netherlands.
Like the large international non-interventional Wide
AmbispectiVE study of the clinical management and
burden of Bipolar Disorder (WAVE-bd) [25], this study
will provide information on a wide variety of treatments
in the clinical management of bipolar disorder.
So far data on naturalistic treatment of bipolar disorder
in the Netherlands are mainly available from patients who
participated in the multicenter multinational longitudinal
study of the former Stanley Foundation Bipolar Network
[26,27]. However, that study included patients who were
motivated to participate in intensive longitudinal and
interventional research, and thus may not be representative
for the average outpatient. We therefore intended to create
a minimal threshold for participation and no interference
with ongoing treatment.
A second aim of the study is to assess concordance of
treatments with the Dutch guideline. When investigating
concordance with treatment guidelines in naturalistic
treatment settings, a problem may be that participating
health care providers may change their habits and start
providing treatments which are more in concordance
with guidelines. Although this may improve the quality
of care for patients participating in a study, it may por-
tray a more favorable outcome than will be the case in
every day practice.
In this study we aim to minimize the influence on
participating health care providers by using written
surveys only and limit the measurements to only two
moments in time. Moreover, information on treatment
details and outcome is given by the patient, who will
be less aware of the recommendations given in the
guideline. Although we assume this will provide more
valid information on current treatments, studies with
written surveys also have limitations.
Non-response with possible selection bias may limit
generalizability of research findings. To minimize se-
lection bias we approached all eligible psychiatrists in
the Netherlands and their patients to participate in the
study. Another limitation that may occur with written
surveys is recall bias. Patients may for instance have
problems remembering visits to health care providers
or medication used. We therefore limited data collec-
tion to the previous 12 month at both time points(with the exception of previous participation in a group
psychoeducation program since patients may have par-
ticipated in such a program more than a year ago prior
to study entry).
Despite these limitations we expect that this study will
contribute to the quality of care for patient with bipolar
disorder by providing information on treatment of bipo-
lar disorder in everyday clinical practice and the impact
of concordance with the guideline. Insight in factors that
are associated with concordance with the guideline will
help to develop more effective strategies to implement
evidence-based treatments in clinical practice. We think
the design of the study is innovative since it combines
information on everyday clinical practice, the impact of
concordance with the guideline and the organization of
care. Moreover concordance with the guideline will be
assessed in different subgroups of patients requiring
different treatment modalities as recommended in the
guideline, instead of more general recommendations.
We hope that with the publication of the methodology of
our study, we will contribute to discussion on how studies
on naturalistic treatments and concordance of treatment
guidelines can be designed, helping to close the cap be-
tween evidence based treatments in guidelines and care in
every day clinical practice.
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